Literature DB >> 32870437

A short digital eye-tracking assessment predicts cognitive status among adults.

Joshua L Gills1, Nick T Bott2, Erica N Madero2, Jordan M Glenn1,2, Michelle Gray3.   

Abstract

Current cognitive assessments suffer from limited scalability and high user burden. This study aimed to (1) examine the relationship between a brief eye-tracking-based visual paired-comparison (VPC) and gold standard cognitive assessments, (2) examine longitudinal stability of the VPC task, (3) determine the ability of the VPC task to differentiate between cognitively normal (CN) individuals and individuals with mild cognitive impairment (MCI). Fifty-five adults (n = 44 CN, n = 11 MCI; 56.4 ± 26.7 years) were tested on two occasions, separated by at least 14 days. Visit 1 included VPC, Montreal Cognitive Assessment (MoCA), Digit Symbol Coding test (DSC), and NIH Toolbox Cognitive Battery (NIHTB-CB). Visit 2 included VPC, DSC, NIHTB-CB, and dual-task (DT). Significant differences existed between baseline VPC scores for CN and MCI groups (p < .001). VPC scores remained stable over time in both groups (p < .05). Significant associations existed between VPC and MoCA (p < .01), DSC (p < .001), and various NIHTB-CB subtests at both time points. The VPC test significantly predicts cognitive outcomes (p < .05), with age and VPC being the only significant predictors. Additionally, area under the curve (receiver operator characteristic = 0.80) for VPC scores demonstrated good classification accuracy. VPC reliably predicted cognitive status while remaining stable over time and displayed significant associations with gold standard cognitive assessments. VPC is a less burdensome and more scalable assessment than traditional tests, enabling longitudinal monitoring of cognitive status in resource-limited environments.

Entities:  

Keywords:  Cognition; Dementia; Eye-tracking; Mild cognitive impairment

Mesh:

Year:  2020        PMID: 32870437      PMCID: PMC8050116          DOI: 10.1007/s11357-020-00254-5

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  17 in total

1.  Habitual and Maximal Dual-Task Gait Speeds Among Sedentary, Recreationally Active, and Masters Athlete Late Middle-Aged Adults.

Authors:  Jordan M Glenn; Jennifer Vincenzo; Collin K Canella; Ashley Binns; Michelle Gray
Journal:  J Aging Phys Act       Date:  2014-10-23       Impact factor: 1.961

2.  Memory in the infant.

Authors:  J F Fagan
Journal:  J Exp Child Psychol       Date:  1970-04

3.  Behavioral and cognitive markers of mild cognitive impairment: diagnostic value of saccadic eye movements and Simon task.

Authors:  Negin Chehrehnegar; Vahid Nejati; Mohsen Shati; Mahdieh Esmaeili; Zahra Rezvani; Marjan Haghi; Mahshid Foroughan
Journal:  Aging Clin Exp Res       Date:  2019-01-18       Impact factor: 3.636

4.  Gait variability and fall risk in community-living older adults: a 1-year prospective study.

Authors:  J M Hausdorff; D A Rios; H K Edelberg
Journal:  Arch Phys Med Rehabil       Date:  2001-08       Impact factor: 3.966

5.  Worth a glance: using eye movements to investigate the cognitive neuroscience of memory.

Authors:  Deborah E Hannula; Robert R Althoff; David E Warren; Lily Riggs; Neal J Cohen; Jennifer D Ryan
Journal:  Front Hum Neurosci       Date:  2010-10-08       Impact factor: 3.169

6.  Reliability and validity of composite scores from the NIH Toolbox Cognition Battery in adults.

Authors:  Robert K Heaton; Natacha Akshoomoff; David Tulsky; Dan Mungas; Sandra Weintraub; Sureyya Dikmen; Jennifer Beaumont; Kaitlin B Casaletto; Kevin Conway; Jerry Slotkin; Richard Gershon
Journal:  J Int Neuropsychol Soc       Date:  2014-06-24       Impact factor: 2.892

7.  An Evaluation of the Longitudinal, Bidirectional Associations Between Gait Speed and Cognition in Older Women and Men.

Authors:  John R Best; Teresa Liu-Ambrose; Robert M Boudreau; Hilsa N Ayonayon; Suzanne Satterfield; Eleanor M Simonsick; Stephanie Studenski; Kristine Yaffe; Anne B Newman; Caterina Rosano
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-10       Impact factor: 6.053

8.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.

Authors:  Michael C Donohue; Reisa A Sperling; David P Salmon; Dorene M Rentz; Rema Raman; Ronald G Thomas; Michael Weiner; Paul S Aisen
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

9.  Age-related decrements in dual-task performance: Comparison of different mobility and cognitive tasks. A cross sectional study.

Authors:  Paolo Riccardo Brustio; Daniele Magistro; Massimiliano Zecca; Emanuela Rabaglietti; Monica Emma Liubicich
Journal:  PLoS One       Date:  2017-07-21       Impact factor: 3.240

10.  Device-Embedded Cameras for Eye Tracking-Based Cognitive Assessment: Validation With Paper-Pencil and Computerized Cognitive Composites.

Authors:  Nicholas Bott; Erica N Madero; Jordan Glenn; Alexander Lange; John Anderson; Doug Newton; Adam Brennan; Elizabeth A Buffalo; Dorene Rentz; Stuart Zola
Journal:  J Med Internet Res       Date:  2018-07-24       Impact factor: 5.428

View more
  3 in total

Review 1.  Affective Computing for Late-Life Mood and Cognitive Disorders.

Authors:  Erin Smith; Eric A Storch; Ipsit Vahia; Stephen T C Wong; Helen Lavretsky; Jeffrey L Cummings; Harris A Eyre
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

2.  Acute Inositol-Stabilized Arginine Silicate Improves Cognitive Outcomes in Healthy Adults.

Authors:  Joshua L Gills; Anthony Campitelli; Megan Jones; Sally Paulson; Jennifer Rae Myers; Erica N Madero; Jordan M Glenn; James Komorowski; Michelle Gray
Journal:  Nutrients       Date:  2021-11-26       Impact factor: 5.717

3.  Intervention for a Digital, Cognitive, Multi-Domain Alzheimer Risk Velocity Study: Protocol for a Randomized Controlled Trial.

Authors:  Michelle Gray; Erica N Madero; Joshua L Gills; Sally Paulson; Megan D Jones; Anthony Campitelli; Jennifer Myers; Nicholas T Bott; Jordan M Glenn
Journal:  JMIR Res Protoc       Date:  2022-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.